InvestorsHub Logo

Venture_Cap

05/14/20 2:35 PM

#78054 RE: Leronlimab4DaWin #78047

Yes, very concerning. In this world though shady people stumble upon gold mines all the time. So long as the world (and us) benefits from their need for greed then I’m fine with it. If leronlimab truly works then oh my.

Normyshorts

05/14/20 3:12 PM

#78070 RE: Leronlimab4DaWin #78047

I am member of cool blue. I resent you have called me a convicted fraud. I have never been convicted of fraud. (convicted? no.. never convicted. - Bill Murray) Where do i go to get the record corrected of your false accusation?

read up on "dreamcathers". a long time ago as a young man before he was an engineer or CEO of cydy he was accused of selling Indian Dreamcatchers and the argument was with Native Americans having a problem saying "Indians" when they were not made by "approved native americans" But good on you to throw dust and crap in the air...

Blane

05/14/20 3:27 PM

#78077 RE: Leronlimab4DaWin #78047

1). How many other CCR5 receptor blockers are in clinical trials for the indications Cytodyn is pursuing, WITHOUT SAEs to boot? I’ll wait.

2). Dr. Bruce Patterson correctly noted the distinction of how the inflammatory process is initiated, they didn’t ‘switch’ anything. But nice try trying to pin some sort of ‘consirscy’ on management. Pathophysiology much?

3). Management sold what was rightfully theirs to sell. They didn’t even HAVE TO put anything back into the company, but they did.

4). It is typical for pre-revenue companies to pay to promote their company. Even big pharma does so with all their pharmaceuticals. I mean, why advertise if a drug works, right? Or are they looking to make more sales too?

5). Don’t really care as long as the message coming from the company is accurate.

6). This is a non-point. He was never convicted. This needs to stop being brought up as it has absolutely NO bearing on Cytodyn.

7). Seems like you’ll have to take that up with Cool Blue Capital. Still doesn’t Co anger the fundamentals of the drug, it’s development, progress or future outcomes.

Next!